Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias P Ebert

Showing results (111-120 of 139) with videos related to

Pageof 14
Sort By:
The American Journal of Pathology|October 22, 2011
MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancerBenjamin Balluff, Sandra Rauser, Stephan Meding, et al.
Oncoimmunology|October 25, 2019
Docking protein-1 promotes inflammatory macrophage signaling in gastric cancerTong Li, Beifang Li, Asgharpour Sara, et al.
European Journal of Cancer (Oxford, England : 1990)|October 20, 2023
Deep learning trained on lymph node status predicts outcome from gastric cancer histopathology: a retrospective multicentric studyHannah S Muti, Christoph Röcken, Hans-Michael Behrens, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 3, 2017
Diagnosing autoimmune pancreatitis with the Unifying-Autoimmune-Pancreatitis-CriteriaAlexander Schneider, Henrik Michaely, Felix Rückert, et al.
Pharmacoeconomics|February 4, 2026
Bevacizumab for Metastatic Colorectal Cancer with Chromosomal Instability: Cost-Effectiveness Analysis for a Novel Precision Treatment Approach in Germany, Ireland and SpainJonathan Briody, Ian S Miller, James F O'Mahony, et al.
Oncology Research and Treatment|September 5, 2025
Structured magnetic resonance imaging assessment improves diagnosis of pathological complete response in rectal cancer after neoadjuvant chemoradiationMoying Li, Tobias Dieckmann, Florian Herrle, et al.
Cell & Bioscience|March 15, 2026
Semi-automated isolation of parenchymal and non-parenchymal liver cells from mice and humans with enhanced stellate cell fractionAnne Dropmann, Bedair Dewidar, Kerry Gould, et al.
Journal of Geriatric Oncology|August 3, 2024
Functional status and quality of life in older patients with advanced esophageal squamous cell cancer receiving second-line nivolumab ± ipilimumab therapy: A post hoc analysis of the phase 2, multicenter RAMONA studyMoying Li, Nadja M Meindl-Beinker, Martin Maenz, et al.
Ebiomedicine|July 14, 2019
Aryl hydrocarbon receptor nuclear translocator-like (ARNTL/BMAL1) is associated with bevacizumab resistance in colorectal cancer via regulation of vascular endothelial growth factor AElke Burgermeister, Francesca Battaglin, Fagr Eladly, et al.
The American Journal of Pathology|October 11, 2023
Insulin Determines Transforming Growth Factor β Effects on Hepatocyte Nuclear Factor 4α Transcription in HepatocytesRilu Feng, Chenhao Tong, Tao Lin, et al.
Pageof 14

Showing results (111-120 of 139) with videos related to

Sort By:
Pageof 14
The American Journal of Pathology|October 22, 2011
MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancerBenjamin Balluff, Sandra Rauser, Stephan Meding, et al.
Oncoimmunology|October 25, 2019
Docking protein-1 promotes inflammatory macrophage signaling in gastric cancerTong Li, Beifang Li, Asgharpour Sara, et al.
European Journal of Cancer (Oxford, England : 1990)|October 20, 2023
Deep learning trained on lymph node status predicts outcome from gastric cancer histopathology: a retrospective multicentric studyHannah S Muti, Christoph Röcken, Hans-Michael Behrens, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 3, 2017
Diagnosing autoimmune pancreatitis with the Unifying-Autoimmune-Pancreatitis-CriteriaAlexander Schneider, Henrik Michaely, Felix Rückert, et al.
Pharmacoeconomics|February 4, 2026
Bevacizumab for Metastatic Colorectal Cancer with Chromosomal Instability: Cost-Effectiveness Analysis for a Novel Precision Treatment Approach in Germany, Ireland and SpainJonathan Briody, Ian S Miller, James F O'Mahony, et al.
Oncology Research and Treatment|September 5, 2025
Structured magnetic resonance imaging assessment improves diagnosis of pathological complete response in rectal cancer after neoadjuvant chemoradiationMoying Li, Tobias Dieckmann, Florian Herrle, et al.
Cell & Bioscience|March 15, 2026
Semi-automated isolation of parenchymal and non-parenchymal liver cells from mice and humans with enhanced stellate cell fractionAnne Dropmann, Bedair Dewidar, Kerry Gould, et al.
Journal of Geriatric Oncology|August 3, 2024
Functional status and quality of life in older patients with advanced esophageal squamous cell cancer receiving second-line nivolumab ± ipilimumab therapy: A post hoc analysis of the phase 2, multicenter RAMONA studyMoying Li, Nadja M Meindl-Beinker, Martin Maenz, et al.
Ebiomedicine|July 14, 2019
Aryl hydrocarbon receptor nuclear translocator-like (ARNTL/BMAL1) is associated with bevacizumab resistance in colorectal cancer via regulation of vascular endothelial growth factor AElke Burgermeister, Francesca Battaglin, Fagr Eladly, et al.
The American Journal of Pathology|October 11, 2023
Insulin Determines Transforming Growth Factor β Effects on Hepatocyte Nuclear Factor 4α Transcription in HepatocytesRilu Feng, Chenhao Tong, Tao Lin, et al.
Pageof 14